As patient expectations continue to evolve, brick-and-mortar pharmacy’s path forward lies in combining trusted, face-to-face care with the efficiency and convenience patients increasingly value.
Commentary|Podcasts|September 30, 2024
Incorporating AI into Commercialization Plans
Author(s)Nicholas Saraceno, Senior Editor
Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.
Advertisement
In this exclusive PC Podcast interview, Steve Silvestro, president of OptimizeRx, a digital communications platform, details:
- The benefits to integrating direct-to-consumer (DTC) and healthcare provider (HCP) marketing strategies with technology, especially for patients and providers
- The application of artificial intelligence (AI) toward the pharma marketing stage of commercialization
- Ways that pharma marketers can navigate the rapidly changing landscape of state-level consumer privacy legislation
- Recommendations for pharma brands as they start to think about 2025 planning
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Advertisement
Related to this article
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
Valerie Bandy of Tecsys on where 340B rebate mechanics threaten pharmacy purchasing, and how stakeholders can prevent disruption.
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this Pharma Pulse special.
Simvera PSP applies queueing science so manufacturers can test the cost and patient impact of hub staffing decisions before locking them in.
Authenticx CEO Amy Brown on why patient support AI needs continuous oversight, not just adoption.
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
Sponsored
Joe Reynolds, Head of User Experience Services at Noble, breaks down what it really takes for pharmaceutical companies to move therapy from the clinic into the patient's home.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Supply Chain Signal: How Policy Pressures Are Converging on Pharma
2
Pharma Pulse: Vicapsys-Stateline Merger and Veritiv's TempSafe RxShield
3
Copeland Closes Dickson Deal to Expand Cold Chain Monitoring
4
FAQ: What Comes Next for the 340B Rebate Pilot
5